http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004254121-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
filingDate | 2003-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db45a00a2b5a1d2010e626fe4182eb7c |
publicationDate | 2004-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2004254121-A1 |
titleOfInvention | Intrauterine growth restriction - and a postulated treatment modality for clinical research and it's biochemical rationale |
abstract | Intrauterine fetal growth restriction (IUGR) is a very important clinical problem for which no satisfactory treatment is available so far. The current invention of IV hypertonic glucose supplementation to the mother to improve the glucose transfer to the fetus at the intervillous space by improved facilitated diffusion can be a safe and easy way of treating this problem, as the improved fetal blood glucose can lead to fetal lipogenesis that can conserve the fetal O 2 utilization, relieves the associated metabolic derangements of fetal hypoxia, hypercapnea, and acidosis, apart from replenishing the oxidized coenzymes needed for the carbohydrate metabolism. The use of transamniotic fetal feeding (TAFF), studied by animal experiments, can be difficult in humans, because of the dangers of infection, which can be overcome by the use of implantable ports with the sterile patch technique. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2732873-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010035352-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007047196-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109068986-A |
priorityDate | 2003-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 854.